WILLIAM J DAWSON
CIK 1226139 · Chief Financial Officer · last filed 2026-03-03
WILLIAM J DAWSON is a Chief Financial Officer who has filed 58 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for MGRC, was dated Mar 3, 2026. Across all open-market trades the lifetime net is −$5.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.24M
3
58
-$5.10M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MGRC | Director | 7,300 | $115.09 | $840.2K | -$5.20M | 45 | 2026-03-03 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | Chief Financial Officer | 14,284 | $8.22 | $117.4K | -$12.2K | 5 | 2017-03-22 |
| CERS | Chief Financial Officer | 156,825 | $2.56 | $401.5K | $108.7K | 8 | 2009-01-14 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-03 | MGRC | Grant (A) | +1,300 | $0 | EDGAR |
| 2025-04-03 | MGRC | Exer (M) | +1,000 | $0 | EDGAR |
| 2025-02-25 | MGRC | Grant (A) | +1,000 | $0 | EDGAR |
| 2024-10-30 | MGRC | Sell (S) | −20,000 | -$2.30M | EDGAR |
| 2024-04-03 | MGRC | Exer (M) | +1,200 | $0 | EDGAR |
| 2024-02-27 | MGRC | Grant (A) | — | $0 | EDGAR |
| 2023-04-05 | MGRC | Exer (M) | +1,500 | $0 | EDGAR |
| 2023-02-27 | MGRC | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | MGRC | Exer (M) | +1,500 | $0 | EDGAR |
| 2022-02-28 | MGRC | Grant (A) | — | $0 | EDGAR |